The evolutionary role of the IL-33/ST2 system in host immune defence

Archivum Immunologiae et Therapiae Experimentalis

Volumn 61, Issue 2, 2013, Pages 107-117

  Sattler, Susanne ^a   Smits, Hermelijn H ^b   Xu, Damo ^c   Huang, Fang Ping ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Host defence; IL 33; Immune response; Infection; Infectious disease; ST2

Indexed keywords

INTERLEUKIN 33; RECEPTOR PROTEIN; ST2 PROTEIN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; BACTERIAL INFECTION; CELL ACTIVATION; CELL FUNCTION; EXTRACELLULAR SPACE; HOST RESISTANCE; HUMAN; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MOLECULAR EVOLUTION; MYCOSIS; NONHUMAN; PARASITOSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; VIRUS INFECTION;

ADAPTIVE IMMUNITY; ANIMALS; BIOLOGICAL EVOLUTION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INFECTION; INTERLEUKIN-1; INTERLEUKINS; RECEPTORS, CELL SURFACE;

EID: 84879462169     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-012-0208-8     Document Type: Review

References (79)

1. Albonico M, Savioli L (1997) Hookworm infection and disease: advances for control. Ann Ist Super Sanita 33:567-579 (Pubitemid 28311097)
2. Ali S, Mohs A, Thomas M et al (2011) The dual function cytokine IL-33 interacts with the transcription factor NF-kappaB to dampen NF-kappaB-stimulated gene transcription. J Immunol 187:1609-1616
3. Allakhverdi Z, Smith DE, Comeau MR et al (2007) Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol 179:2051-2054
4. Alves-Filho JC, Sonego F, Souto FO et al (2010) Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat Med 16:708-712
5. Antignano F, Mullaly SC, Burrows K et al (2011) Trichuris muris infection: a model of type 2 immunity and inflammation in the gut. J Vis Exp pii: 2774
6. Baekkevold ES, Roussigne M, Yamanaka T et al (2003) Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol 163:69-79 (Pubitemid 36759592)
7. Becerra A, Warke RV, de Bosch N et al (2008) Elevated levels of soluble ST2 protein in dengue virus infected patients. Cytokine 41:114-120
8. Besnard AG, Togbe D, Guillou N et al (2011) IL-33-activated dendritic cells are critical for allergic airway inflammation. Eur J Immunol 41:1675-1686
9. + T cell responses. Science 335:984-989
10. Bourgeois E, Van LP, Samson M et al (2009) The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur J Immunol 39:1046-1055
11. Brough D, Le Feuvre RA, Iwakura Y et al (2002) Purinergic (P2X7) receptor activation of microglia induces cell death via an interleukin-1-independent mechanism. Mol Cell Neurosci 19:272-280 (Pubitemid 34211906)
12. Carriere V, Roussel L, Ortega N et al (2007) IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci USA 104:282-287 (Pubitemid 46068023)
13. Cayrol C, Girard JP (2009) The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci USA 106:9021-9026
14. Chang YJ, Kim HY, Albacker et al (2011) Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 12:631-638
15. Chaturvedi U, Nagar R, Shrivastava R (2006) Dengue and dengue haemorrhagic fever: implications of host genetics. FEMS Immunol Med Microbiol 47:155-166 (Pubitemid 43881735)
16. Enoksson M, Lyberg K, Moller-Westerberg C et al (2011) Mast cells as sensors of cell injury through IL-33 recognition. J Immunol 186:2523-2528
17. Espinassous Q, Garcia-de-Paco E, Garcia-Verdugo I et al (2009) IL-33 enhances lipopolysaccharide-induced inflammatory cytokine production from mouse macrophages by regulating lipopolysaccharide receptor complex. J Immunol 183:1446-1455
18. Gillibert-Duplantier J, Duthey B, Sisirak V et al (2012) Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasis. Oncogene 31:3516-3524
19. Guo L, Wei G, Zhu J et al (2009) IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc Natl Acad Sci USA 106:13463-13468
20. Hansen JD, Vojtech LN, Laing KJ (2011) Sensing disease and danger: a survey of vertebrate PRRs and their origins. Dev Comp Immunol 35:886-897
21. Haraldsen G, Balogh J, Pollheimer J et al (2009) Interleukin-33 - cytokine of dual function or novel alarmin? Trends Immunol 30:227-233
22. Hayakawa H, Hayakawa M, Kume A et al (2007) Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 282:26369-26380 (Pubitemid 47443815)
23. Hazlett LD, McClellan SA, Barrett RP et al (2010) IL-33 shifts macrophage polarization, promoting resistance against Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci 51:1524-1532
24. Houghton-Trivino N, Salgado DM, Rodriguez JA et al (2010) Levels of soluble ST2 in serum associated with severity of dengue due to tumour necrosis factor alpha stimulation. J Gen Virol 91(Pt 3):697-706
25. Hudson CA, Christophi GP, Gruber RC et al (2008) Induction of IL-33 expression and activity in central nervous system glia. J Leukoc Biol 84:631-643
26. Huising MO, Stet RJ, Savelkoul HF et al (2004) The molecular evolution of the interleukin-1 family of cytokines; IL-18 in teleost fish. Dev Comp Immunol 28:395-413 (Pubitemid 38177444)
27. Humphreys NE, Xu D, Hepworth MR et al (2008) IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J Immunol 180:2443-2449
28. Jones LA, Roberts F, Nickdel MB et al (2010) IL-33 receptor (T1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii. Eur J Immunol 40:426-436
29. Kakkar R, Hei H, Dobner S et al (2012) Interleukin 33 as a mechanically responsive cytokine secreted by living cells. J Biol Chem 287:6941-6948
30. Keller M, Ruegg A, Werner S et al (2008) Active caspase-1 is a regulator of unconventional protein secretion. Cell 132:818-831 (Pubitemid 351312798)
31. Klune JR, Dhupar R, Cardinal J et al (2008) HMGB1: endogenous danger signaling. Mol Med 14:476-484
32. Komai-Koma M, Xu D, Li Y et al (2007) IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol 37:2779-2786 (Pubitemid 47578297)
33. Komai-Koma M, Gilchrist DS, McKenzie AN et al (2011) IL-33 activates B1 cells and exacerbates contact sensitivity. J Immunol 186:2584-2591
34. Kouzaki H, Iijima K, Kobayashi T et al (2011) The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses. J Immunol 186:4375-4387
35. + Th2 cells in Leishmania major infection. Eur J Immunol 32:2450-2459
36. Kropf P, Herath S, Klemenz R et al (2003) Signaling through the T1/ST2 molecule is not necessary for Th2 differentiation but is important for the regulation of type 1 responses in nonhealing Leishmania major infection. Infect Immun 71:1961-1971 (Pubitemid 36368729)
37. Kurowska-Stolarska M, Stolarski B, Kewin P et al (2009) IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol 183:6469-6477
38. Le Goffic R, Arshad MI, Rauch M et al (2011) Infection with influenza virus induces IL-33 in murine lungs. Am J Respir Cell Mol Biol 45:1125-1132
39. Le HT, Tran VG, Kim W et al (2012) IL-33 priming regulates multiple steps of the neutrophil-mediated anti-Candida albicans response by modulating TLR and dectin-1 signals. J Immunol 189:287-295
40. Lefrancais E, Roga S, Gautier V et al (2012) IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc Natl Acad Sci USA 109:1673-1678
41. Liew FY (2012) IL-33: a Janus cytokine. Ann Rheum Dis 71(Suppl 2):i101-i104
42. Liew FY, Pitman NI, McInnes IB (2010) Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 10:103-110
43. Lohning M, Stroehmann A, Coyle AJ et al (1998) T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci USA 95:6930-6935 (Pubitemid 28278084)
44. Luthi AU, Cullen SP, McNeela EA et al (2009) Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 31:84-98
45. Medzhitov R, Schneider DS, Soares MP (2012) Disease tolerance as a defense strategy. Science 335:936-941
46. Monticelli LA, Sonnenberg GF, Abt MC et al (2011) Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 12:1045-1054
47. Moussion C, Ortega N, Girard JP (2008) The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS One 3:e3331
48. Nagata A, Takezako N, Tamemoto H et al (2012) Soluble ST2 protein inhibits LPS stimulation on monocyte-derived dendritic cells. Cell Mol Immunol 9:399-409
49. Neill DR, Wong SH, Bellosi A et al (2010) Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464:1367-1370
50. Nelson MP, Christmann BS, Werner JL et al (2011) IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina. J Immunol 186:2372-2381
51. Nile CJ, Barksby E, Jitprasertwong P et al (2010) Expression and regulation of interleukin-33 in human monocytes. Immunology 130:172-180
52. Oboki K, Ohno T, Kajiwara N et al (2010) IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci USA 107:18581-18586
53. Onda H, Kasuya H, Takakura K et al (1999) Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage. J Cereb Blood Flow Metab 19:1279-1288 (Pubitemid 30176457)
54. Paul WE, Zhu J (2010) How are T(H)2-type immune responses initiated and amplified? Nat Rev Immunol 10:225-235
55. Pecaric-Petkovic T, Didichenko SA, Kaempfer S et al (2009) Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 113:1526-1534
56. Peiris JS, Cheung CY, Leung CY et al (2009) Innate immune responses to influenza A H5N1: friend or foe? Trends Immunol 30:574-584
57. Pichery M, Mirey E, Mercier P et al (2012) Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J Immunol 188:3488-3495
58. Polumuri SK, Jayakar GG, Shirey KA et al (2012) Transcriptional regulation of murine IL-33 by TLR and non-TLR agonists. J Immunol 189:50-60
59. Price AE, Liang HE, Sullivan BM et al (2010) Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci USA 107:11489-11494
60. Robert-Gangneux F, Darde ML (2012) Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 25:264-296
61. Schlenke TA, Begun DJ (2003) Natural selection drives Drosophila immune system evolution. Genetics 164:1471-1480 (Pubitemid 37102209)
62. Schmitz J, Owyang A, Oldham E et al (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23:479-490 (Pubitemid 41587888)
63. Shimosato T, Fujimoto M, Tohno M et al (2010) CpG oligodeoxynucleotides induce strong up-regulation of interleukin 33 via Toll-like receptor 9. Biochem Biophys Res Commun 394:81-86
64. Smith DE (2010) IL-33: a tissue derived cytokine pathway involved in allergic inflammation and asthma. Clin Exp Allergy 40:200-208
65. Smithgall MD, Comeau MR, Yoon BR et al (2008) IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int Immunol 20:1019-1030
66. Spits H, Cupedo T (2012) Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol 30:647-675
67. Stein C, Caccamo M, Laird G et al (2007) Conservation and divergence of gene families encoding components of innate immune response systems in zebrafish. Genome Biol 8:R251 (Pubitemid 351917498)
68. Suzukawa M, Iikura M, Koketsu R et al (2008) An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J Immunol 181:5981-5989
69. Takezako N, Hayakawa M, Hayakawa H et al (2006) ST2 suppresses IL-6 production via the inhibition of IkappaB degradation induced by the LPS signal in THP-1 cells. Biochem Biophys Res Commun 341:425-432 (Pubitemid 43152122)
70. Tominaga S, Jenkins NA, Gilbert DJ et al (1991) Molecular cloning of the murine ST2 gene. Characterization and chromosomal mapping. Biochim Biophys Acta 1090:1-8
71. Wagenaar JF, Gasem MH, Goris MG et al (2009) Soluble ST2 levels are associated with bleeding in patients with severe Leptospirosis. PLoS Negl Trop Dis 3:e453
72. Wieland CW, van der Windt GJ, Florquin S et al (2009) ST2 deficient mice display a normal host defense against pulmonary infection with Mycobacterium tuberculosis. Microbes Infect 11:524-530
73. Wilhelm C, Stockinger B (2011) Innate lymphoid cells and type 2 (th2) mediated immune responses - pathogenic or beneficial? Front Immunol 2:68
74. Xu D, Chan WL, Leung BP et al (1998) Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med 187:787-794 (Pubitemid 28115194)
75. Xu D, Jiang HR, Kewin P et al (2008) IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci USA 105:10913-10918
76. Yanagisawa K, Takagi T, Tsukamoto T et al (1993) Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1. FEBS Lett 318:83-87 (Pubitemid 23057042)
77. + T cells. Eur J Immunol 41:3351-3360
78. Yasuda K, Muto T, Kawagoe T et al (2012) Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. Proc Natl Acad Sci USA 109:3451-3456
79. Zhang L, Lu R, Zhao G et al (2011) TLR-mediated induction of pro-allergic cytokine IL-33 in ocular mucosal epithelium. Int J Biochem Cell Biol 43:1383-1391